SynthesisJAMA network open2023

Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis.

Brandon A Mahal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.